Assessment of Confirmed Clinical Hypersensitivity to Rituximab in Patients Affected with B-Cell Neoplasia

Assessment of Confirmed Clinical Hypersensitivity to Rituximab in Patients Affected with B-Cell Neoplasia

Rituximab hypersensitivity reactions are rare but are one of the main causes of rituximab elimination from antilymphoma immunochemotherapy treatments. While the clinical picture may be indistinguishable from other infusion-related reactions, hypersensitivity reactions (HSR) do not disappear and inst...

Full description

Bibliographic Details
Main Authors: S. Novelli, L. Soto, A. Caballero, M. E. Moreno, M. J. Lara, D. Bayo, A. Quintas, P. Jimeno, M. I. Zamora, T. Bigorra, J. Sierra, J. Briones
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2020/4231561

Similar Items

Similar Items